这是一篇来自已证抗体库的有关人类 IL-6 (IL-6) 的综述,是根据119篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合IL-6 抗体。
IL-6 同义词: BSF-2; BSF2; CDF; HGF; HSF; IFN-beta-2; IFNB2; IL-6; interleukin-6; B-cell differentiation factor; B-cell stimulatory factor 2; CTL differentiation factor; hybridoma growth factor; interferon beta-2; interleukin BSF-2

艾博抗(上海)贸易有限公司
小鼠 单克隆
  • 免疫组化-石蜡切片; 小鼠; 图 3d
艾博抗(上海)贸易有限公司IL-6抗体(Abcam, ab9324)被用于被用于免疫组化-石蜡切片在小鼠样品上 (图 3d). Br J Pharmacol (2018) ncbi
小鼠 单克隆
  • 免疫组化-石蜡切片; 人类; 图 6a
艾博抗(上海)贸易有限公司IL-6抗体(Abcam, ab9324)被用于被用于免疫组化-石蜡切片在人类样品上 (图 6a). J Cell Biochem (2018) ncbi
小鼠 单克隆
  • 免疫组化; 人类; 图 1f
艾博抗(上海)贸易有限公司IL-6抗体(Abcam, ab9324)被用于被用于免疫组化在人类样品上 (图 1f). Int J Mol Sci (2017) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 1:500; 图 5h
艾博抗(上海)贸易有限公司IL-6抗体(Abcam, ab6672)被用于被用于免疫印迹在小鼠样品上浓度为1:500 (图 5h). PLoS ONE (2017) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:1000; 图 4a
艾博抗(上海)贸易有限公司IL-6抗体(Abcam, ab6672)被用于被用于免疫印迹在人类样品上浓度为1:1000 (图 4a). Cell Death Dis (2017) ncbi
兔 多克隆
  • 免疫组化; 小鼠; 1.1 ug/ml; 图 7
艾博抗(上海)贸易有限公司IL-6抗体(Abcam, ab6672)被用于被用于免疫组化在小鼠样品上浓度为1.1 ug/ml (图 7). Oncotarget (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图 1
艾博抗(上海)贸易有限公司IL-6抗体(Abcam, ab6672)被用于被用于免疫印迹在人类样品上 (图 1). Oncol Lett (2016) ncbi
兔 多克隆
  • 免疫组化; 大鼠; 1:100; 图 3
  • 免疫印迹; 大鼠; 图 4
艾博抗(上海)贸易有限公司IL-6抗体(Abcam, ab6672)被用于被用于免疫组化在大鼠样品上浓度为1:100 (图 3) 和 被用于免疫印迹在大鼠样品上 (图 4). BMC Cancer (2016) ncbi
兔 多克隆
  • 免疫组化-石蜡切片; 人类; 1:400; 图 1
艾博抗(上海)贸易有限公司IL-6抗体(Abcam, ab6672)被用于被用于免疫组化-石蜡切片在人类样品上浓度为1:400 (图 1). Autophagy (2016) ncbi
小鼠 单克隆
  • 免疫组化-石蜡切片; 人类; 1:400; 图 1
艾博抗(上海)贸易有限公司IL-6抗体(Abcam, ab9324)被用于被用于免疫组化-石蜡切片在人类样品上浓度为1:400 (图 1). Autophagy (2016) ncbi
兔 多克隆
  • 免疫组化-冰冻切片; 大鼠; 图 4
艾博抗(上海)贸易有限公司IL-6抗体(Abcam, ab6672)被用于被用于免疫组化-冰冻切片在大鼠样品上 (图 4). Sci Rep (2016) ncbi
兔 多克隆
  • 免疫印迹; 猪; 1:1000; 图 4
艾博抗(上海)贸易有限公司IL-6抗体(Abcam, ab6672)被用于被用于免疫印迹在猪样品上浓度为1:1000 (图 4). Am J Physiol Regul Integr Comp Physiol (2016) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 图 1a
艾博抗(上海)贸易有限公司IL-6抗体(Abcam, AB6672)被用于被用于免疫印迹在小鼠样品上 (图 1a). Biol Sex Differ (2016) ncbi
小鼠 单克隆
  • 免疫组化-石蜡切片; 人类; 1:3000; 图 5
艾博抗(上海)贸易有限公司IL-6抗体(Abcam, ab9324)被用于被用于免疫组化-石蜡切片在人类样品上浓度为1:3000 (图 5). Oncoimmunology (2016) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 图 6
艾博抗(上海)贸易有限公司IL-6抗体(Abcam, ab6672)被用于被用于免疫印迹在小鼠样品上 (图 6). Sci Rep (2016) ncbi
兔 多克隆
  • 免疫印迹; 大鼠; 1:1000; 图 5
  • 免疫印迹; 人类; 1:1000; 图 3
艾博抗(上海)贸易有限公司IL-6抗体(abcam, ab6672)被用于被用于免疫印迹在大鼠样品上浓度为1:1000 (图 5) 和 被用于免疫印迹在人类样品上浓度为1:1000 (图 3). Sci Rep (2016) ncbi
兔 多克隆
  • 免疫组化; 小鼠; 图 6
艾博抗(上海)贸易有限公司IL-6抗体(Abcam, ab6672)被用于被用于免疫组化在小鼠样品上 (图 6). Mol Cancer (2016) ncbi
兔 多克隆
  • 抑制或激活实验; 人类; 图 6
艾博抗(上海)贸易有限公司IL-6抗体(Abcam, ab6672)被用于被用于抑制或激活实验在人类样品上 (图 6). Sci Rep (2016) ncbi
兔 多克隆
  • 酶联免疫吸附测定; 人类; 表 s4
艾博抗(上海)贸易有限公司IL-6抗体(Abcam, ab6672)被用于被用于酶联免疫吸附测定在人类样品上 (表 s4). ACS Nano (2016) ncbi
兔 多克隆
  • 免疫印迹; 狗; 1:1000; 图 6
艾博抗(上海)贸易有限公司IL-6抗体(Abcam, ab6672)被用于被用于免疫印迹在狗样品上浓度为1:1000 (图 6). Stem Cell Res Ther (2015) ncbi
小鼠 单克隆
  • 免疫组化; 人类; 图 1
艾博抗(上海)贸易有限公司IL-6抗体(Abcam, ab9324)被用于被用于免疫组化在人类样品上 (图 1). PLoS ONE (2015) ncbi
兔 多克隆
  • 免疫组化; 小鼠; 1:200; 图 5f
艾博抗(上海)贸易有限公司IL-6抗体(Abcam, ab6672)被用于被用于免疫组化在小鼠样品上浓度为1:200 (图 5f). Oncogene (2016) ncbi
兔 多克隆
  • 免疫组化; 人类
艾博抗(上海)贸易有限公司IL-6抗体(Abcam, ab6672)被用于被用于免疫组化在人类样品上. Support Care Cancer (2016) ncbi
小鼠 单克隆
  • 免疫组化-石蜡切片; 兔; 0.5 ug/ml; 图 14
艾博抗(上海)贸易有限公司IL-6抗体(Abcam, ab9324)被用于被用于免疫组化-石蜡切片在兔样品上浓度为0.5 ug/ml (图 14). PLoS ONE (2015) ncbi
兔 多克隆
  • 免疫组化-石蜡切片; 小鼠; 1:400; 图 4
艾博抗(上海)贸易有限公司IL-6抗体(Abcam, ab6672)被用于被用于免疫组化-石蜡切片在小鼠样品上浓度为1:400 (图 4). Oncotarget (2015) ncbi
兔 多克隆
  • 免疫组化-石蜡切片; 人类; 1:100
艾博抗(上海)贸易有限公司IL-6抗体(AbCam, ab6672)被用于被用于免疫组化-石蜡切片在人类样品上浓度为1:100. APMIS (2015) ncbi
小鼠 单克隆
  • 酶联免疫吸附测定; 人类
艾博抗(上海)贸易有限公司IL-6抗体(Abcam, Ab9324)被用于被用于酶联免疫吸附测定在人类样品上. Analyst (2015) ncbi
小鼠 单克隆
  • 免疫印迹; 大鼠; 图 4
艾博抗(上海)贸易有限公司IL-6抗体(Abcam, ab9324)被用于被用于免疫印迹在大鼠样品上 (图 4). Am J Obstet Gynecol (2015) ncbi
兔 多克隆
  • 免疫组化-石蜡切片; 小鼠; 1.0 ug/ml
艾博抗(上海)贸易有限公司IL-6抗体(Abcam, ab6672)被用于被用于免疫组化-石蜡切片在小鼠样品上浓度为1.0 ug/ml. Mol Carcinog (2016) ncbi
兔 多克隆
  • immunohistochemistry - free floating section; 人类; 1:100
艾博抗(上海)贸易有限公司IL-6抗体(Abcam, ab6672)被用于被用于immunohistochemistry - free floating section在人类样品上浓度为1:100. J Neuropathol Exp Neurol (2015) ncbi
兔 多克隆
  • 免疫组化-石蜡切片; 小鼠; 1:400
  • 免疫印迹; 小鼠; 1:500
艾博抗(上海)贸易有限公司IL-6抗体(Abcam, ab6672)被用于被用于免疫组化-石蜡切片在小鼠样品上浓度为1:400 和 被用于免疫印迹在小鼠样品上浓度为1:500. Nat Commun (2015) ncbi
兔 多克隆
  • 免疫印迹; 大鼠; 1:500
艾博抗(上海)贸易有限公司IL-6抗体(Abcam Biotechnology, Ab-6672)被用于被用于免疫印迹在大鼠样品上浓度为1:500. Life Sci (2015) ncbi
兔 多克隆
  • 免疫印迹; 大鼠
艾博抗(上海)贸易有限公司IL-6抗体(Abcam, ab6672)被用于被用于免疫印迹在大鼠样品上. Redox Biol (2014) ncbi
小鼠 单克隆
  • 免疫组化-石蜡切片; 人类; 图 2
艾博抗(上海)贸易有限公司IL-6抗体(Abcam, Ab9324)被用于被用于免疫组化-石蜡切片在人类样品上 (图 2). Gynecol Oncol (2015) ncbi
兔 多克隆
  • 免疫组化; 人类; 1:100
  • 免疫印迹; 人类; 1:1000
艾博抗(上海)贸易有限公司IL-6抗体(Abcam, ab6672)被用于被用于免疫组化在人类样品上浓度为1:100 和 被用于免疫印迹在人类样品上浓度为1:1000. Cancer Res (2015) ncbi
兔 多克隆
  • 免疫组化; 小鼠
艾博抗(上海)贸易有限公司IL-6抗体(Abcam, ab6672)被用于被用于免疫组化在小鼠样品上. Cancer Res (2014) ncbi
兔 多克隆
  • 免疫组化-石蜡切片; 大鼠; 1:100
艾博抗(上海)贸易有限公司IL-6抗体(Abcam, ab6672)被用于被用于免疫组化-石蜡切片在大鼠样品上浓度为1:100. Mol Pharm (2014) ncbi
兔 多克隆
  • 免疫印迹; 大鼠
艾博抗(上海)贸易有限公司IL-6抗体(Abcam, ab6672)被用于被用于免疫印迹在大鼠样品上. Brain Behav Immun (2015) ncbi
兔 多克隆
  • 免疫印迹; 大鼠; 1:1000; 图 5e
艾博抗(上海)贸易有限公司IL-6抗体(Abcam, ab6672)被用于被用于免疫印迹在大鼠样品上浓度为1:1000 (图 5e). Mol Neurodegener (2014) ncbi
兔 多克隆
  • 免疫印迹; 小鼠
艾博抗(上海)贸易有限公司IL-6抗体(Abcam, ab6672)被用于被用于免疫印迹在小鼠样品上. Exp Parasitol (2014) ncbi
兔 多克隆
  • 免疫组化; 大鼠
艾博抗(上海)贸易有限公司IL-6抗体(Abcam, ab6672)被用于被用于免疫组化在大鼠样品上. PLoS ONE (2014) ncbi
兔 多克隆
  • 免疫组化-石蜡切片; 小鼠
艾博抗(上海)贸易有限公司IL-6抗体(Abcam, ab6672)被用于被用于免疫组化-石蜡切片在小鼠样品上. Am J Physiol Heart Circ Physiol (2014) ncbi
兔 多克隆
  • 免疫组化-石蜡切片; 大鼠
艾博抗(上海)贸易有限公司IL-6抗体(Abcam, ab6672)被用于被用于免疫组化-石蜡切片在大鼠样品上. World J Gastroenterol (2014) ncbi
兔 多克隆
  • 免疫组化-石蜡切片; 大鼠
  • 免疫组化-石蜡切片; 人类
艾博抗(上海)贸易有限公司IL-6抗体(Abcam, ab6672)被用于被用于免疫组化-石蜡切片在大鼠样品上 和 被用于免疫组化-石蜡切片在人类样品上. Cell Death Dis (2013) ncbi
兔 多克隆
  • 免疫组化-冰冻切片; 大鼠; 1:400
艾博抗(上海)贸易有限公司IL-6抗体(Abcam, ab6672)被用于被用于免疫组化-冰冻切片在大鼠样品上浓度为1:400. J Cereb Blood Flow Metab (2013) ncbi
兔 多克隆
  • 免疫组化-石蜡切片; 小鼠
艾博抗(上海)贸易有限公司IL-6抗体(Abcam, ab6672)被用于被用于免疫组化-石蜡切片在小鼠样品上. Exp Toxicol Pathol (2013) ncbi
兔 多克隆
  • 免疫组化; 小鼠; 1:600
艾博抗(上海)贸易有限公司IL-6抗体(Abcam, ab6672)被用于被用于免疫组化在小鼠样品上浓度为1:600. Oncogene (2014) ncbi
兔 多克隆
  • 免疫组化-石蜡切片; 大鼠; 1:200
  • 免疫印迹; 大鼠; 1:500
艾博抗(上海)贸易有限公司IL-6抗体(Abcam, ab6672)被用于被用于免疫组化-石蜡切片在大鼠样品上浓度为1:200 和 被用于免疫印迹在大鼠样品上浓度为1:500. PLoS ONE (2012) ncbi
赛默飞世尔
大鼠 单克隆(MQ2-13A5)
  • 流式细胞仪; 人类; 图 3
赛默飞世尔IL-6抗体(eBioscience, MQ2-13A5)被用于被用于流式细胞仪在人类样品上 (图 3). Eur J Immunol (2017) ncbi
大鼠 单克隆(MQ2-13A5)
  • 其他; 人类; 表 1
赛默飞世尔IL-6抗体(eBioscience, 14-7069-85)被用于被用于其他在人类样品上 (表 1). Dis Markers (2016) ncbi
大鼠 单克隆(MQ2-39C3)
  • 其他; 人类; 表 1
赛默飞世尔IL-6抗体(eBioscience, 13-7068-85)被用于被用于其他在人类样品上 (表 1). Dis Markers (2016) ncbi
大鼠 单克隆(MQ2-13A5)
  • 流式细胞仪; 人类; 图 s6
赛默飞世尔IL-6抗体(eBioscience, 56-7069-42)被用于被用于流式细胞仪在人类样品上 (图 s6). Proc Natl Acad Sci U S A (2016) ncbi
大鼠 单克隆(MQ2-13A5)
  • 其他; 人类; 图 6
赛默飞世尔IL-6抗体(eBioscience, 14-7069)被用于被用于其他在人类样品上 (图 6). Talanta (2016) ncbi
小鼠 单克隆(505E23C7)
  • 其他; 人类; 表 1
赛默飞世尔IL-6抗体(Thermo Fisher, 505E223C7)被用于被用于其他在人类样品上 (表 1). Breast Cancer (Dove Med Press) (2016) ncbi
小鼠 单克隆(5IL6)
  • 其他; 人类; 表 1
赛默飞世尔IL-6抗体(Thermo Fisher, 5IL6)被用于被用于其他在人类样品上 (表 1). Breast Cancer (Dove Med Press) (2016) ncbi
大鼠 单克隆(MQ2-39C3)
  • 酶联免疫吸附测定; 人类; 图 s10
赛默飞世尔IL-6抗体(Affymetrix eBioscience, 13-7068-81)被用于被用于酶联免疫吸附测定在人类样品上 (图 s10). ACS Nano (2016) ncbi
小鼠 单克隆(5IL6)
  • 酶联免疫吸附测定; 人类
赛默飞世尔IL-6抗体(Pierce Protein Biology Products, M620)被用于被用于酶联免疫吸附测定在人类样品上. Br J Clin Pharmacol (2015) ncbi
大鼠 单克隆(MQ2-13A5)
  • 酶联免疫吸附测定; 人类
赛默飞世尔IL-6抗体(eBioscience, 12?C7069?C81)被用于被用于酶联免疫吸附测定在人类样品上. PLoS ONE (2015) ncbi
大鼠 单克隆(MQ2-39C3)
  • 酶联免疫吸附测定; 人类
赛默飞世尔IL-6抗体(eBioscience, 13?C7068?C81)被用于被用于酶联免疫吸附测定在人类样品上. PLoS ONE (2015) ncbi
小鼠 单克隆(677B6A2)
  • 免疫细胞化学; 人类
  • 酶联免疫吸附测定; 人类
赛默飞世尔IL-6抗体(Life Technologies/Invitrogen Corporation, AHC0562)被用于被用于免疫细胞化学在人类样品上 和 被用于酶联免疫吸附测定在人类样品上. Biochim Biophys Acta (2015) ncbi
大鼠 单克隆(MQ2-13A5)
  • 流式细胞仪; 人类; 图 2
赛默飞世尔IL-6抗体(eBioscience, MQ2-13A5)被用于被用于流式细胞仪在人类样品上 (图 2). J Infect Dis (2015) ncbi
大鼠 单克隆(MQ2-39C3)
  • 酶联免疫吸附测定; 人类; 图 1
赛默飞世尔IL-6抗体(eBioscience, MQ2-39C3)被用于被用于酶联免疫吸附测定在人类样品上 (图 1). Anal Chem (2014) ncbi
大鼠 单克隆(MQ2-13A5)
  • 酶联免疫吸附测定; 人类; 图 1
赛默飞世尔IL-6抗体(eBioscience, MQ2-13A5)被用于被用于酶联免疫吸附测定在人类样品上 (图 1). Anal Chem (2014) ncbi
大鼠 单克隆(MQ2-13A5)
  • 流式细胞仪; 人类; 1 ug/ml; 图 3
赛默飞世尔IL-6抗体(eBioscience, MQ2-13A5)被用于被用于流式细胞仪在人类样品上浓度为1 ug/ml (图 3). PLoS ONE (2013) ncbi
小鼠 单克隆(677B6A2)
  • 酶联免疫吸附测定; 人类; 图 1
赛默飞世尔IL-6抗体(Biosource, clone 677B 6A2)被用于被用于酶联免疫吸附测定在人类样品上 (图 1). Arthritis (2011) ncbi
小鼠 单克隆(677B6A2)
  • 免疫细胞化学; 人类; 1:10; 图 3
赛默飞世尔IL-6抗体(Biosource, 677B6A2)被用于被用于免疫细胞化学在人类样品上浓度为1:10 (图 3). Rejuvenation Res (2011) ncbi
小鼠 单克隆(677B6A2)
  • 酶联免疫吸附测定; 人类; 图 6
赛默飞世尔IL-6抗体(Invitrogen, AHC0562)被用于被用于酶联免疫吸附测定在人类样品上 (图 6). PLoS ONE (2011) ncbi
大鼠 单克隆(MQ2-13A5)
  • 抑制或激活实验; 人类; 表 1
赛默飞世尔IL-6抗体(eBioscience, MQ2-13A5)被用于被用于抑制或激活实验在人类样品上 (表 1). Clin Cancer Res (2008) ncbi
小鼠 单克隆(677B6A2)
  • 免疫沉淀; 人类
赛默飞世尔IL-6抗体(Biosource, AHC0562)被用于被用于免疫沉淀在人类样品上. J Neuroimmunol (2008) ncbi
小鼠 单克隆(677B6A2)
  • 免疫组化-石蜡切片; 人类; 20 ug/ml
赛默飞世尔IL-6抗体(Biosource, 677B6A2)被用于被用于免疫组化-石蜡切片在人类样品上浓度为20 ug/ml. Glia (2008) ncbi
小鼠 单克隆(677B6A2)
  • 酶联免疫吸附测定; 人类
赛默飞世尔IL-6抗体(Biosource, 677B6A2)被用于被用于酶联免疫吸附测定在人类样品上. Inflamm Bowel Dis (2007) ncbi
小鼠 单克隆(677B6A2)
  • 酶联免疫吸附测定; 人类; 图 3
赛默飞世尔IL-6抗体(Biosource, 677B6A2)被用于被用于酶联免疫吸附测定在人类样品上 (图 3). Clin Exp Immunol (2006) ncbi
小鼠 单克隆(677B6A2)
  • 酶联免疫吸附测定; 人类
赛默飞世尔IL-6抗体(Biosource, 677B6A2)被用于被用于酶联免疫吸附测定在人类样品上. Immunology (2006) ncbi
小鼠 单克隆(677B6A2)
  • 酶联免疫吸附测定; 人类
赛默飞世尔IL-6抗体(Biosource, 677B6A2)被用于被用于酶联免疫吸附测定在人类样品上. Endocrinology (2002) ncbi
小鼠 单克隆(5IL6)
  • 酶联免疫吸附测定; 人类; 图 1
赛默飞世尔IL-6抗体(Endogen, M620E)被用于被用于酶联免疫吸附测定在人类样品上 (图 1). Exp Lung Res (2002) ncbi
小鼠 单克隆(7IL6)
  • 酶联免疫吸附测定; 人类; 图 1
赛默飞世尔IL-6抗体(Endogen, M621E)被用于被用于酶联免疫吸附测定在人类样品上 (图 1). Exp Lung Res (2002) ncbi
BioLegend
大鼠 单克隆(MQ2-13A5)
  • 流式细胞仪; 人类; 图 5c
BioLegendIL-6抗体(Biolegend, 501112)被用于被用于流式细胞仪在人类样品上 (图 5c). J Clin Invest (2018) ncbi
大鼠 单克隆(MQ2-13A5)
  • 酶联免疫吸附测定; 人类; 图 3d
BioLegendIL-6抗体(BioLegend, 501114)被用于被用于酶联免疫吸附测定在人类样品上 (图 3d). Nat Commun (2018) ncbi
大鼠 单克隆(MQ2-13A5)
  • 流式细胞仪; 人类; 图 2
BioLegendIL-6抗体(Biolegend, 501112)被用于被用于流式细胞仪在人类样品上 (图 2). Retrovirology (2016) ncbi
大鼠 单克隆(MQ2-13A5)
  • 流式细胞仪; 人类; 图 5h
BioLegendIL-6抗体(Biolegend, MQ2-13A5)被用于被用于流式细胞仪在人类样品上 (图 5h). Cytokine (2016) ncbi
大鼠 单克隆(MQ2-13A5)
  • 流式细胞仪; 人类
BioLegendIL-6抗体(Biolegend, 501113)被用于被用于流式细胞仪在人类样品上. Scand J Med Sci Sports (2016) ncbi
大鼠 单克隆(MQ2-13A5)
  • 流式细胞仪; 人类
BioLegendIL-6抗体(Biolegend, 501103)被用于被用于流式细胞仪在人类样品上. Hum Immunol (2015) ncbi
大鼠 单克隆(MQ2-39C3)
  • dot blot; 人类; 表 s1
BioLegendIL-6抗体(Biolegend, 501204)被用于被用于dot blot在人类样品上 (表 s1). Proc Natl Acad Sci U S A (2015) ncbi
大鼠 单克隆(MQ2-13A5)
  • dot blot; 人类; 表 s1
BioLegendIL-6抗体(Biolegend, 501102)被用于被用于dot blot在人类样品上 (表 s1). Proc Natl Acad Sci U S A (2015) ncbi
大鼠 单克隆(MQ2-13A5)
  • 流式细胞仪; 人类
BioLegendIL-6抗体(Biolegend, MQ2-13A5)被用于被用于流式细胞仪在人类样品上. Immunology (2015) ncbi
大鼠 单克隆(MQ2-13A5)
  • 流式细胞仪; 人类
BioLegendIL-6抗体(BioLegend, MQ2-13A5)被用于被用于流式细胞仪在人类样品上. Virol J (2014) ncbi
大鼠 单克隆(MQ2-13A5)
  • 流式细胞仪; 人类; 图 3
BioLegendIL-6抗体(BioLegend, MQ2-13A5)被用于被用于流式细胞仪在人类样品上 (图 3). J Leukoc Biol (2014) ncbi
安迪生物R&D
山羊 多克隆
  • 免疫印迹; 人类; 图 1b
安迪生物R&DIL-6抗体(R&D Systems, AB-206-NA)被用于被用于免疫印迹在人类样品上 (图 1b). Cancer Cell (2018) ncbi
小鼠 单克隆(6708)
  • 其他; 人类; 图 s1
安迪生物R&DIL-6抗体(R&D Systems, MAB206)被用于被用于其他在人类样品上 (图 s1). Cell Chem Biol (2017) ncbi
小鼠 单克隆(1936)
  • 抑制或激活实验; 人类; 图 6e
安迪生物R&DIL-6抗体(R&D Systems, MAB2061)被用于被用于抑制或激活实验在人类样品上 (图 6e). JCI Insight (2016) ncbi
小鼠 单克隆(1936)
  • 抑制或激活实验; 人类; 图 6a
安迪生物R&DIL-6抗体(R&D Systems, MAB2061)被用于被用于抑制或激活实验在人类样品上 (图 6a). Biochem Pharmacol (2016) ncbi
小鼠 单克隆(1936)
  • 流式细胞仪; 人类; 图 2g
安迪生物R&DIL-6抗体(R&D Systems, 1936)被用于被用于流式细胞仪在人类样品上 (图 2g). Sci Rep (2016) ncbi
小鼠 单克隆(1936)
  • 抑制或激活实验; 人类; 图 3d
安迪生物R&DIL-6抗体(R&D Systems, 1936)被用于被用于抑制或激活实验在人类样品上 (图 3d). Eur J Immunol (2016) ncbi
小鼠 单克隆(1936)
  • 免疫组化-石蜡切片; 人类; 图 2b
安迪生物R&DIL-6抗体(R&D Systems, MAB2061)被用于被用于免疫组化-石蜡切片在人类样品上 (图 2b). J Thyroid Res (2016) ncbi
小鼠 单克隆(1936)
  • 免疫组化-石蜡切片; 人类; 图 1
安迪生物R&DIL-6抗体(R&D Systems, MAB2061)被用于被用于免疫组化-石蜡切片在人类样品上 (图 1). Clin Breast Cancer (2016) ncbi
山羊 多克隆
  • proximity ligation assay; 人类
安迪生物R&DIL-6抗体(R&D Systems, BAF206)被用于被用于proximity ligation assay在人类样品上. BMC Cancer (2014) ncbi
山羊 多克隆
  • 抑制或激活实验; 人类; 3 ug/ml
安迪生物R&DIL-6抗体(R&D, AB-206-NA)被用于被用于抑制或激活实验在人类样品上浓度为3 ug/ml. Sci Signal (2014) ncbi
山羊 多克隆
  • 抑制或激活实验; 人类
安迪生物R&DIL-6抗体(R&D Systems, AB-206-NA)被用于被用于抑制或激活实验在人类样品上. Autophagy (2014) ncbi
圣克鲁斯生物技术
小鼠 单克隆(C12-1-hIL-6)
  • 免疫印迹; 小鼠; 1:1000; 图 5c
圣克鲁斯生物技术IL-6抗体(Santa Cruz Biotechnology, Inc, sc-32296)被用于被用于免疫印迹在小鼠样品上浓度为1:1000 (图 5c). Mol Med Rep (2018) ncbi
小鼠 单克隆(1)
  • 免疫印迹; 人类; 1:1000; 图 5d
圣克鲁斯生物技术IL-6抗体(SantaCruz, sc-130326)被用于被用于免疫印迹在人类样品上浓度为1:1000 (图 5d). Mol Med Rep (2017) ncbi
小鼠 单克隆(1)
  • 免疫印迹; 人类; 1:1000; 图 3b
圣克鲁斯生物技术IL-6抗体(Santa Cruz, sc-130326)被用于被用于免疫印迹在人类样品上浓度为1:1000 (图 3b). Int J Mol Med (2017) ncbi
小鼠 单克隆(E-4)
  • 免疫细胞化学; 人类; 图 3d
  • 免疫印迹; 人类; 1:500; 图 3l
圣克鲁斯生物技术IL-6抗体(Santa Cruz Biotechnology, sc-28343)被用于被用于免疫细胞化学在人类样品上 (图 3d) 和 被用于免疫印迹在人类样品上浓度为1:500 (图 3l). Eur J Immunol (2016) ncbi
小鼠 单克隆(1)
  • 免疫组化-石蜡切片; 人类; 5 ug/ml
圣克鲁斯生物技术IL-6抗体(Santa Cruz, sc-130326)被用于被用于免疫组化-石蜡切片在人类样品上浓度为5 ug/ml. Mol Cancer Ther (2014) ncbi
武汉三鹰
兔 多克隆
  • 免疫印迹; 大鼠; 1:500; 图 1e
武汉三鹰IL-6抗体(Proteintech, 21865-1-AP)被用于被用于免疫印迹在大鼠样品上浓度为1:500 (图 1e). Int J Biochem Cell Biol (2016) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 1:1000; 图 4a
武汉三鹰IL-6抗体(Proteintech, 21865-1-AP)被用于被用于免疫印迹在小鼠样品上浓度为1:1000 (图 4a). J Forensic Leg Med (2016) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 1:2000; 图 7d,7e,7f
武汉三鹰IL-6抗体(Proteintech, 21865-1-AP)被用于被用于免疫印迹在小鼠样品上浓度为1:2000 (图 7d,7e,7f). Placenta (2015) ncbi
北京傲锐东源
小鼠 单克隆(OTI3G9)
  • 免疫印迹; 人类; 图 8
北京傲锐东源IL-6抗体(Origene, 3G9)被用于被用于免疫印迹在人类样品上 (图 8). J Neurosci (2016) ncbi
GeneTex
兔 多克隆
  • 免疫组化-冰冻切片; 人类; 1:10000
GeneTexIL-6抗体(Genetex, GTX26672)被用于被用于免疫组化-冰冻切片在人类样品上浓度为1:10000. J Appl Physiol (1985) (2012) ncbi
赛信通(上海)生物试剂有限公司
兔 单克隆(D3K2N)
  • 免疫印迹; 人类; 图 5d
赛信通(上海)生物试剂有限公司IL-6抗体(Cell Signaling, 12153S)被用于被用于免疫印迹在人类样品上 (图 5d). Adv Healthc Mater (2016) ncbi
兔 单克隆(D3K2N)
  • 免疫印迹; 人类; 1:1000; 图 5c
赛信通(上海)生物试剂有限公司IL-6抗体(Cell Signaling, 12153)被用于被用于免疫印迹在人类样品上浓度为1:1000 (图 5c). Am J Pathol (2016) ncbi
兔 单克隆(D3K2N)
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司IL-6抗体(Cell Signaling Technology, D3K2N)被用于被用于免疫印迹在人类样品上. J Neurosci (2016) ncbi
碧迪BD
大鼠 单克隆(MQ2-13A5)
  • 抑制或激活实验; 人类; 图 s5a
碧迪BDIL-6抗体(BD Biosciences, 554543)被用于被用于抑制或激活实验在人类样品上 (图 s5a). Cell (2018) ncbi
大鼠 单克隆(MQ2-13A5)
  • 流式细胞仪; 人类; 图 2b
碧迪BDIL-6抗体(BD Biosciences, MQ2-13A5)被用于被用于流式细胞仪在人类样品上 (图 2b). Front Immunol (2017) ncbi
小鼠 单克隆(AS12)
  • 流式细胞仪; 人类
碧迪BDIL-6抗体(BD, 340527)被用于被用于流式细胞仪在人类样品上. Cell (2017) ncbi
大鼠 单克隆(MQ2-6A3)
  • 流式细胞仪; 人类
碧迪BDIL-6抗体(BD, MQ2-6A3)被用于被用于流式细胞仪在人类样品上. J Immunol (2016) ncbi
大鼠 单克隆(MQ2-6A3)
  • 流式细胞仪; African green monkey; 图 5a
碧迪BDIL-6抗体(BD Biosciences, MQ2-6A3)被用于被用于流式细胞仪在African green monkey样品上 (图 5a). Infect Immun (2016) ncbi
大鼠 单克隆(MQ2-13A5)
  • 流式细胞仪; 狗; 图 2
  • 流式细胞仪; 人类; 图 2
碧迪BDIL-6抗体(BD, 554545)被用于被用于流式细胞仪在狗样品上 (图 2) 和 被用于流式细胞仪在人类样品上 (图 2). Acta Vet Scand (2015) ncbi
大鼠 单克隆(MQ2-6A3)
  • 流式细胞仪; 小鼠; 图 4b
碧迪BDIL-6抗体(BD Pharmingen, 559068)被用于被用于流式细胞仪在小鼠样品上 (图 4b). Nat Commun (2015) ncbi
大鼠 单克隆(MQ2-13A5)
  • 流式细胞仪; 人类; 图 6
碧迪BDIL-6抗体(BD, 561441)被用于被用于流式细胞仪在人类样品上 (图 6). J Exp Med (2015) ncbi
小鼠 单克隆(AS12)
  • 流式细胞仪; 人类
碧迪BDIL-6抗体(BD Pharmingen, clone AS12)被用于被用于流式细胞仪在人类样品上. Chest (2015) ncbi
大鼠 单克隆(MQ2-13A5)
  • 流式细胞仪; 人类
碧迪BDIL-6抗体(BD Biosciences, MQ2-13A5)被用于被用于流式细胞仪在人类样品上. PLoS ONE (2014) ncbi
大鼠 单克隆(MQ2-6A3)
  • 流式细胞仪; 人类
碧迪BDIL-6抗体(BD PharMingen, 554697)被用于被用于流式细胞仪在人类样品上. Eur J Immunol (2014) ncbi
默克密理博中国
小鼠 单克隆(A1)
  • 抑制或激活实验; 人类; 图 5a
默克密理博中国IL-6抗体(Millipore, A1)被用于被用于抑制或激活实验在人类样品上 (图 5a). J Virol (2017) ncbi
小鼠 单克隆(B-E8)
  • immunohistochemistry - free floating section; 人类; 1:200; 图 6
默克密理博中国IL-6抗体(Millipore, CBL2117)被用于被用于immunohistochemistry - free floating section在人类样品上浓度为1:200 (图 6). Sci Rep (2016) ncbi
兔 多克隆
  • 酶联免疫吸附测定; 人类; 图 4
默克密理博中国IL-6抗体(Merck Millipore, AB1431)被用于被用于酶联免疫吸附测定在人类样品上 (图 4). J Virol (2015) ncbi
小鼠 单克隆(B-E8)
  • 免疫印迹; 人类
默克密理博中国IL-6抗体(Millipore, CBL2117)被用于被用于免疫印迹在人类样品上. J Diabetes (2016) ncbi
西格玛奥德里奇
小鼠 单克隆(6708.11)
  • 抑制或激活实验; 人类; 图 3a
西格玛奥德里奇IL-6抗体(Sigma, 6708.11)被用于被用于抑制或激活实验在人类样品上 (图 3a). Oncotarget (2016) ncbi
Developmental Studies Hybridoma Bank
小鼠 单克隆(CPTC-IL6-1)
  • 免疫组化; 人类; 图 3c
Developmental Studies Hybridoma BankIL-6抗体(Developmental Studies Hybridoma Bank, CPTC-IL6-1)被用于被用于免疫组化在人类样品上 (图 3c). Genes Dev (2016) ncbi
文章列表
  1. Kang L, Kwon E, Lee K, Cho C, Lee J, Ryu Y, et al. 3'-Sialyllactose as an inhibitor of p65 phosphorylation ameliorates the progression of experimental rheumatoid arthritis. Br J Pharmacol. 2018;175:4295-4309 pubmed 出版商
  2. Burton A, Pallett L, McCoy L, Suveizdyte K, Amin O, Swadling L, et al. Circulating and intrahepatic antiviral B cells are defective in hepatitis B. J Clin Invest. 2018;128:4588-4603 pubmed 出版商
  3. Georgilis A, Klotz S, Hanley C, Herranz N, Weirich B, Morancho B, et al. PTBP1-Mediated Alternative Splicing Regulates the Inflammatory Secretome and the Pro-tumorigenic Effects of Senescent Cells. Cancer Cell. 2018;34:85-102.e9 pubmed 出版商
  4. Song J, Zhang X, Ge Q, Yuan C, Chu L, Liang H, et al. CRISPR/Cas9-mediated knockout of HBsAg inhibits proliferation and tumorigenicity of HBV-positive hepatocellular carcinoma cells. J Cell Biochem. 2018;119:8419-8431 pubmed 出版商
  5. Zhang Z, Zhang H, Chen R, Wang Z. Oral supplementation with ursolic acid ameliorates sepsis-induced acute kidney injury in a mouse model by inhibiting oxidative stress and inflammatory responses. Mol Med Rep. 2018;17:7142-7148 pubmed 出版商
  6. Wolf D, Anto Michel N, Blankenbach H, Wiedemann A, Buscher K, Hohmann J, et al. A ligand-specific blockade of the integrin Mac-1 selectively targets pathologic inflammation while maintaining protective host-defense. Nat Commun. 2018;9:525 pubmed 出版商
  7. Su S, Chen J, Yao H, Liu J, Yu S, Lao L, et al. CD10+GPR77+ Cancer-Associated Fibroblasts Promote Cancer Formation and Chemoresistance by Sustaining Cancer Stemness. Cell. 2018;172:841-856.e16 pubmed 出版商
  8. Jiang Z, Wang W, Guo C. Tetrahydroxy stilbene glucoside ameliorates H2O2-induced human brain microvascular endothelial cell dysfunction in vitro by inhibiting oxidative stress and inflammatory responses. Mol Med Rep. 2017;16:5219-5224 pubmed 出版商
  9. Vitallé J, Zenarruzabeitia O, Terrén I, Plana M, Guardo A, Leal L, et al. Monocytes Phenotype and Cytokine Production in Human Immunodeficiency Virus-1 Infected Patients Receiving a Modified Vaccinia Ankara-Based HIV-1 Vaccine: Relationship to CD300 Molecules Expression. Front Immunol. 2017;8:836 pubmed 出版商
  10. Shah F, Stepan A, O Mahony A, Velichko S, Folias A, Houle C, et al. Mechanisms of Skin Toxicity Associated with Metabotropic Glutamate Receptor 5 Negative Allosteric Modulators. Cell Chem Biol. 2017;24:858-869.e5 pubmed 出版商
  11. Mitterreiter J, Ouwendijk W, van Velzen M, van Nierop G, Osterhaus A, Verjans G. Satellite glial cells in human trigeminal ganglia have a broad expression of functional Toll-like receptors. Eur J Immunol. 2017;47:1181-1187 pubmed 出版商
  12. Uzan J, Laas E, Alsamad I, Skalli D, Mansouri D, Haddad B, et al. Supervised Clustering of Adipokines and Hormonal Receptors Predict Prognosis in a Population of Obese Women with Type 1 Endometrial Cancer. Int J Mol Sci. 2017;18: pubmed 出版商
  13. Decalf J, Desdouits M, Rodrigues V, Gobert F, Gentili M, Marques Ladeira S, et al. Sensing of HIV-1 Entry Triggers a Type I Interferon Response in Human Primary Macrophages. J Virol. 2017;91: pubmed 出版商
  14. Tian Y, Wu X, Guo S, Ma L, Huang W, Zhao X. Minocycline attenuates sevoflurane-induced cell injury via activation of Nrf2. Int J Mol Med. 2017;39:869-878 pubmed 出版商
  15. Israel L, Wang Y, Bulek K, Della Mina E, Zhang Z, Pedergnana V, et al. Human Adaptive Immunity Rescues an Inborn Error of Innate Immunity. Cell. 2017;168:789-800.e10 pubmed 出版商
  16. Loomis Z, Eigenberger P, Redinius K, Lisk C, Karoor V, Nozik Grayck E, et al. Hemoglobin induced cell trauma indirectly influences endothelial TLR9 activity resulting in pulmonary vascular smooth muscle cell activation. PLoS ONE. 2017;12:e0171219 pubmed 出版商
  17. Guicciardi M, Krishnan A, Bronk S, Hirsova P, Griffith T, Gores G. Biliary tract instillation of a SMAC mimetic induces TRAIL-dependent acute sclerosing cholangitis-like injury in mice. Cell Death Dis. 2017;8:e2535 pubmed 出版商
  18. Spivak A, Larragoite E, Coletti M, Macedo A, Martins L, Bosque A, et al. Janus kinase inhibition suppresses PKC-induced cytokine release without affecting HIV-1 latency reversal ex vivo. Retrovirology. 2016;13:88 pubmed 出版商
  19. Formica F, Öztürk E, Hess S, Stark W, Maniura Weber K, Rottmar M, et al. A Bioinspired Ultraporous Nanofiber-Hydrogel Mimic of the Cartilage Extracellular Matrix. Adv Healthc Mater. 2016;5:3129-3138 pubmed 出版商
  20. Khalaj K, Luna R, de França M, de Oliveira W, Peixoto C, Tayade C. RNA binding protein, tristetraprolin in a murine model of recurrent pregnancy loss. Oncotarget. 2016;7:72486-72502 pubmed 出版商
  21. Oon S, Huynh H, Tai T, Ng M, Monaghan K, Biondo M, et al. A cytotoxic anti-IL-3Rα antibody targets key cells and cytokines implicated in systemic lupus erythematosus. JCI Insight. 2016;1:e86131 pubmed 出版商
  22. De Paoli M, Gogalic S, Sauer U, Preininger C, Pandha H, Simpson G, et al. Multiplatform Biomarker Discovery for Bladder Cancer Recurrence Diagnosis. Dis Markers. 2016;2016:4591910 pubmed
  23. Wu J, Hu G, Lu Y, Zheng J, Chen J, Wang X, et al. Palmitic acid aggravates inflammation of pancreatic acinar cells by enhancing unfolded protein response induced CCAAT-enhancer-binding protein ?-CCAAT-enhancer-binding protein ? activation. Int J Biochem Cell Biol. 2016;79:181-193 pubmed 出版商
  24. Zhou Q, Yu X, Demirkaya E, Deuitch N, Stone D, Tsai W, et al. Biallelic hypomorphic mutations in a linear deubiquitinase define otulipenia, an early-onset autoinflammatory disease. Proc Natl Acad Sci U S A. 2016;113:10127-32 pubmed 出版商
  25. Makki M, Haqqi T. Histone Deacetylase Inhibitor Vorinostat (SAHA) Suppresses IL-1?-Induced Matrix Metallopeptidase-13 Expression by Inhibiting IL-6 in Osteoarthritis Chondrocyte. Am J Pathol. 2016;186:2701-8 pubmed 出版商
  26. Neumann L, Mueller M, Moos V, Heller F, Meyer T, Loddenkemper C, et al. Mucosal Inducible NO Synthase-Producing IgA+ Plasma Cells in Helicobacter pylori-Infected Patients. J Immunol. 2016;197:1801-8 pubmed 出版商
  27. Shi K, Qian J, Qi L, Mao D, Chen Y, Zhu Y, et al. Atorvastatin antagonizes the visfatin-induced expression of inflammatory mediators via the upregulation of NF-?B activation in HCAECs. Oncol Lett. 2016;12:1438-1444 pubmed
  28. Knobloch J, Yanik S, Körber S, Stoelben E, Jungck D, Koch A. TNF?-induced airway smooth muscle cell proliferation depends on endothelin receptor signaling, GM-CSF and IL-6. Biochem Pharmacol. 2016;116:188-99 pubmed 出版商
  29. Piancone F, Saresella M, Marventano I, La Rosa F, Zoppis M, Agostini S, et al. B Lymphocytes in Multiple Sclerosis: Bregs and BTLA/CD272 Expressing-CD19+ Lymphocytes Modulate Disease Severity. Sci Rep. 2016;6:29699 pubmed 出版商
  30. Garcia P, Seiva F, Carniato A, de Mello Júnior W, Duran N, Macedo A, et al. Increased toll-like receptors and p53 levels regulate apoptosis and angiogenesis in non-muscle invasive bladder cancer: mechanism of action of P-MAPA biological response modifier. BMC Cancer. 2016;16:422 pubmed 出版商
  31. Cheng W, van Asten S, Burns L, Evans H, Walter G, Hashim A, et al. Periodontitis-associated pathogens P. gingivalis and A. actinomycetemcomitans activate human CD14(+) monocytes leading to enhanced Th17/IL-17 responses. Eur J Immunol. 2016;46:2211-21 pubmed 出版商
  32. Xie L, Zhou F, Liu X, Fang Y, Yu Z, Song N, et al. Serum microRNA181a: Correlates with the intracellular cytokine levels and a potential biomarker for acute graft-versus-host disease. Cytokine. 2016;85:37-44 pubmed 出版商
  33. Hageneder S, Bauch M, Dostalek J. Plasmonically amplified bioassay - Total internal reflection fluorescence vs. epifluorescence geometry. Talanta. 2016;156-157:225-231 pubmed 出版商
  34. Hendrayani S, Al Harbi B, Al Ansari M, Silva G, Aboussekhra A. The inflammatory/cancer-related IL-6/STAT3/NF-?B positive feedback loop includes AUF1 and maintains the active state of breast myofibroblasts. Oncotarget. 2016;7:41974-41985 pubmed 出版商
  35. Xue H, Yuan G, Guo X, Liu Q, Zhang J, Gao X, et al. A novel tumor-promoting mechanism of IL6 and the therapeutic efficacy of tocilizumab: Hypoxia-induced IL6 is a potent autophagy initiator in glioblastoma via the p-STAT3-MIR155-3p-CREBRF pathway. Autophagy. 2016;12:1129-52 pubmed 出版商
  36. Holditch S, Schreiber C, Burnett J, Ikeda Y. Arterial Remodeling in B-Type Natriuretic Peptide Knock-Out Females. Sci Rep. 2016;6:25623 pubmed 出版商
  37. Bouvier D, Jones E, Quesseveur G, Davoli M, A Ferreira T, Quirion R, et al. High Resolution Dissection of Reactive Glial Nets in Alzheimer's Disease. Sci Rep. 2016;6:24544 pubmed 出版商
  38. Kobawala T, Trivedi T, Gajjar K, Patel D, Patel G, Ghosh N. Significance of Interleukin-6 in Papillary Thyroid Carcinoma. J Thyroid Res. 2016;2016:6178921 pubmed 出版商
  39. Ganesan S, Reynolds C, Hollinger K, Pearce S, Gabler N, Baumgard L, et al. Twelve hours of heat stress induces inflammatory signaling in porcine skeletal muscle. Am J Physiol Regul Integr Comp Physiol. 2016;310:R1288-96 pubmed 出版商
  40. Mishra V, DiAngelo S, Silveyra P. Sex-specific IL-6-associated signaling activation in ozone-induced lung inflammation. Biol Sex Differ. 2016;7:16 pubmed 出版商
  41. Mertz K, Mager L, Wasmer M, Thiesler T, Koelzer V, Ruzzante G, et al. The IL-33/ST2 pathway contributes to intestinal tumorigenesis in humans and mice. Oncoimmunology. 2016;5:e1062966 pubmed
  42. Casneuf T, Axel A, King P, ALVAREZ J, Werbeck J, Verhulst T, et al. Interleukin-6 is a potential therapeutic target in interleukin-6 dependent, estrogen receptor-α-positive breast cancer. Breast Cancer (Dove Med Press). 2016;8:13-27 pubmed 出版商
  43. Wang L, Zhao R, Liu C, Liu M, Li S, Li J, et al. A fundamental study on the dynamics of multiple biomarkers in mouse excisional wounds for wound age estimation. J Forensic Leg Med. 2016;39:138-46 pubmed 出版商
  44. Liu Z, Gan L, Chen Y, Luo D, Zhang Z, Cao W, et al. Mark4 promotes oxidative stress and inflammation via binding to PPARγ and activating NF-κB pathway in mice adipocytes. Sci Rep. 2016;6:21382 pubmed 出版商
  45. Phuah J, Wong E, Gideon H, Maiello P, Coleman M, Hendricks M, et al. Effects of B Cell Depletion on Early Mycobacterium tuberculosis Infection in Cynomolgus Macaques. Infect Immun. 2016;84:1301-1311 pubmed 出版商
  46. Zhao J, Wang L, Dong X, Hu X, Zhou L, Liu Q, et al. The c-Jun N-terminal kinase (JNK) pathway is activated in human interstitial cystitis (IC) and rat protamine sulfate induced cystitis. Sci Rep. 2016;6:19670 pubmed 出版商
  47. Capell B, Drake A, Zhu J, Shah P, Dou Z, Dorsey J, et al. MLL1 is essential for the senescence-associated secretory phenotype. Genes Dev. 2016;30:321-36 pubmed 出版商
  48. Theendakara V, Peters Libeu C, Spilman P, Poksay K, Bredesen D, Rao R. Direct Transcriptional Effects of Apolipoprotein E. J Neurosci. 2016;36:685-700 pubmed 出版商
  49. Yeh C, Slavin S, Da J, Hsu I, Luo J, Xiao G, et al. Estrogen receptor α in cancer associated fibroblasts suppresses prostate cancer invasion via reducing CCL5, IL6 and macrophage infiltration in the tumor microenvironment. Mol Cancer. 2016;15:7 pubmed 出版商
  50. Jhaveri K, Teplinsky E, Silvera D, Valeta Magara A, Arju R, Giashuddin S, et al. Hyperactivated mTOR and JAK2/STAT3 Pathways: Molecular Drivers and Potential Therapeutic Targets of Inflammatory and Invasive Ductal Breast Cancers After Neoadjuvant Chemotherapy. Clin Breast Cancer. 2016;16:113-22.e1 pubmed 出版商
  51. Zhao C, Zhang W, Zhao Y, Yang Y, Luo H, Ji G, et al. Endothelial Cords Promote Tumor Initial Growth prior to Vascular Function through a Paracrine Mechanism. Sci Rep. 2016;6:19404 pubmed 出版商
  52. Piraino F, Volpetti F, Watson C, Maerkl S. A Digital-Analog Microfluidic Platform for Patient-Centric Multiplexed Biomarker Diagnostics of Ultralow Volume Samples. ACS Nano. 2016;10:1699-710 pubmed 出版商
  53. Kim Y, Jo S, Kim W, Kweon O. Antioxidant and anti-inflammatory effects of intravenously injected adipose derived mesenchymal stem cells in dogs with acute spinal cord injury. Stem Cell Res Ther. 2015;6:229 pubmed 出版商
  54. Fraveto A, Cardinale V, Bragazzi M, Giuliante F, De Rose A, Grazi G, et al. Sensitivity of Human Intrahepatic Cholangiocarcinoma Subtypes to Chemotherapeutics and Molecular Targeted Agents: A Study on Primary Cell Cultures. PLoS ONE. 2015;10:e0142124 pubmed 出版商
  55. Schminke B, Trautmann S, Mai B, Miosge N, Blaschke S. Interleukin 17 inhibits progenitor cells in rheumatoid arthritis cartilage. Eur J Immunol. 2016;46:440-5 pubmed 出版商
  56. Manda K, Tripathi P, Hsi A, Ning J, Ruzinova M, Liapis H, et al. NFATc1 promotes prostate tumorigenesis and overcomes PTEN loss-induced senescence. Oncogene. 2016;35:3282-92 pubmed 出版商
  57. Wardill H, Logan R, Bowen J, Van Sebille Y, Gibson R. Tight junction defects are seen in the buccal mucosa of patients receiving standard dose chemotherapy for cancer. Support Care Cancer. 2016;24:1779-88 pubmed 出版商
  58. Moreira M, Dorneles E, Soares R, Magalhães C, Costa Pereira C, Lage A, et al. Cross-reactivity of commercially available anti-human monoclonal antibodies with canine cytokines: establishment of a reliable panel to detect the functional profile of peripheral blood lymphocytes by intracytoplasmic staining. Acta Vet Scand. 2015;57:51 pubmed 出版商
  59. Wang C, Li H, Luo C, Li Y, Zhang Y, Yun D, et al. The effect of maternal obesity on the expression and functionality of placental P-glycoprotein: Implications in the individualized transplacental digoxin treatment for fetal heart failure. Placenta. 2015;36:1138-47 pubmed 出版商
  60. Oliver R, Lovric V, Yu Y, Christou C, Aiken S, Cooper J, et al. Development of a Novel Model for the Assessment of Dead-Space Management in Soft Tissue. PLoS ONE. 2015;10:e0136514 pubmed 出版商
  61. Binder Gallimidi A, Fischman S, Revach B, Bulvik R, Maliutina A, Rubinstein A, et al. Periodontal pathogens Porphyromonas gingivalis and Fusobacterium nucleatum promote tumor progression in an oral-specific chemical carcinogenesis model. Oncotarget. 2015;6:22613-23 pubmed
  62. Singh N, Kotla S, Dyukova E, Traylor J, Orr A, Chernoff J, et al. Disruption of p21-activated kinase 1 gene diminishes atherosclerosis in apolipoprotein E-deficient mice. Nat Commun. 2015;6:7450 pubmed 出版商
  63. Andreasen S, Therkildsen M, Grauslund M, Friis Hansen L, Wessel I, Homøe P. Activation of the interleukin-6/Janus kinase/STAT3 pathway in pleomorphic adenoma of the parotid gland. APMIS. 2015;123:706-15 pubmed 出版商
  64. van de Vyver M, Engelbrecht L, Smith C, Myburgh K. Neutrophil and monocyte responses to downhill running: Intracellular contents of MPO, IL-6, IL-10, pstat3, and SOCS3. Scand J Med Sci Sports. 2016;26:638-47 pubmed 出版商
  65. Boisson B, Laplantine E, Dobbs K, Cobat A, Tarantino N, Hazen M, et al. Human HOIP and LUBAC deficiency underlies autoinflammation, immunodeficiency, amylopectinosis, and lymphangiectasia. J Exp Med. 2015;212:939-51 pubmed 出版商
  66. Westcott M, Liu J, Rajani K, D AGOSTINO R, Lyles D, Porosnicu M. Interferon Beta and Interferon Alpha 2a Differentially Protect Head and Neck Cancer Cells from Vesicular Stomatitis Virus-Induced Oncolysis. J Virol. 2015;89:7944-54 pubmed 出版商
  67. Madaboosi N, Soares R, Chu V, Conde J. A microfluidic immunoassay platform for the detection of free prostate specific antigen: a systematic and quantitative approach. Analyst. 2015;140:4423-33 pubmed 出版商
  68. Dell Ovo V, Rosenzweig J, Burd I, Merabova N, Darbinian N, Goetzl L. An animal model for chorioamnionitis at term. Am J Obstet Gynecol. 2015;213:387.e1-10 pubmed 出版商
  69. Liu Z, Jiang C, Zhang J, Liu B, Du Q. Resveratrol inhibits inflammation and ameliorates insulin resistant endothelial dysfunction via regulation of AMP-activated protein kinase and sirtuin 1 activities. J Diabetes. 2016;8:324-35 pubmed 出版商
  70. Chaturvedi S, Siegel D, Wagner C, Park J, van de Velde H, Vermeulen J, et al. Development and validation of panoptic Meso scale discovery assay to quantify total systemic interleukin-6. Br J Clin Pharmacol. 2015;80:687-97 pubmed 出版商
  71. Misra R, Shah S, Fowell D, Wang H, Scheible K, Misra S, et al. Preterm cord blood CD4⁺ T cells exhibit increased IL-6 production in chorioamnionitis and decreased CD4⁺ T cells in bronchopulmonary dysplasia. Hum Immunol. 2015;76:329-338 pubmed 出版商
  72. Rao C, Sanghera S, Zhang Y, Biddick L, Reddy A, Lightfoot S, et al. Antagonizing pathways leading to differential dynamics in colon carcinogenesis in Shugoshin1 (Sgo1)-haploinsufficient chromosome instability model. Mol Carcinog. 2016;55:600-10 pubmed 出版商
  73. López González I, Schlüter A, Aso E, Garcia Esparcia P, Ansoleaga B, Llorens F, et al. Neuroinflammatory signals in Alzheimer disease and APP/PS1 transgenic mice: correlations with plaques, tangles, and oligomeric species. J Neuropathol Exp Neurol. 2015;74:319-44 pubmed 出版商
  74. Volpetti F, Garcia Cordero J, Maerkl S. A microfluidic platform for high-throughput multiplexed protein quantitation. PLoS ONE. 2015;10:e0117744 pubmed 出版商
  75. Lu Y, Xue Q, Eisele M, Sulistijo E, Brower K, Han L, et al. Highly multiplexed profiling of single-cell effector functions reveals deep functional heterogeneity in response to pathogenic ligands. Proc Natl Acad Sci U S A. 2015;112:E607-15 pubmed 出版商
  76. Chandler R, Damrauer J, Raab J, Schisler J, Wilkerson M, Didion J, et al. Coexistent ARID1A-PIK3CA mutations promote ovarian clear-cell tumorigenesis through pro-tumorigenic inflammatory cytokine signalling. Nat Commun. 2015;6:6118 pubmed 出版商
  77. Passos E, Pereira C, Gonçalves I, Rocha Rodrigues S, Silva N, Guimarães J, et al. Role of physical exercise on hepatic insulin, glucocorticoid and inflammatory signaling pathways in an animal model of non-alcoholic steatohepatitis. Life Sci. 2015;123:51-60 pubmed 出版商
  78. de Thier P, Bacharouche J, Duval J, Skali Lami S, Francius G. Atomic force microscopy analysis of IgG films at hydrophobic surfaces: a promising method to probe IgG orientations and optimize ELISA tests performance. Biochim Biophys Acta. 2015;1854:138-45 pubmed 出版商
  79. Yang S, Xia C, Li S, Du L, Zhang L, Zhou R. Defective mitophagy driven by dysregulation of rheb and KIF5B contributes to mitochondrial reactive oxygen species (ROS)-induced nod-like receptor 3 (NLRP3) dependent proinflammatory response and aggravates lipotoxicity. Redox Biol. 2014;3:63-71 pubmed 出版商
  80. Bonneau C, Rouzier R, Geyl C, Cortez A, Castela M, Lis R, et al. Predictive markers of chemoresistance in advanced stages epithelial ovarian carcinoma. Gynecol Oncol. 2015;136:112-20 pubmed 出版商
  81. Hautefort A, Girerd B, Montani D, Cohen Kaminsky S, Price L, Lambrecht B, et al. T-helper 17 cell polarization in pulmonary arterial hypertension. Chest. 2015;147:1610-1620 pubmed 出版商
  82. Thompson I, Mann E, Stokes M, English N, Knight S, Williamson D. Specific activation of dendritic cells enhances clearance of Bacillus anthracis following infection. PLoS ONE. 2014;9:e109720 pubmed 出版商
  83. Lee K, Yeo S, Sung C, Kim S. Twist1 is a key regulator of cancer-associated fibroblasts. Cancer Res. 2015;75:73-85 pubmed 出版商
  84. Boltjes A, van Montfoort N, Biesta P, Op den Brouw M, Kwekkeboom J, van der Laan L, et al. Kupffer cells interact with hepatitis B surface antigen in vivo and in vitro, leading to proinflammatory cytokine production and natural killer cell function. J Infect Dis. 2015;211:1268-78 pubmed 出版商
  85. Schillace R, Skinner A, Pommier R, O Neill S, Muller P, Naik A, et al. Estrogen receptor, progesterone receptor, interleukin-6 and interleukin-8 are variable in breast cancer and benign stem/progenitor cell populations. BMC Cancer. 2014;14:733 pubmed 出版商
  86. McElwee J, Mohanan S, Horibata S, Sams K, Anguish L, Mclean D, et al. PAD2 overexpression in transgenic mice promotes spontaneous skin neoplasia. Cancer Res. 2014;74:6306-17 pubmed 出版商
  87. Wang X, Xiong M, Zeng Y, Sun X, Gong T, Zhang Z. Mechanistic studies of a novel mycophenolic acid-glucosamine conjugate that attenuates renal ischemia/reperfusion injury in rat. Mol Pharm. 2014;11:3503-14 pubmed 出版商
  88. Zang Y, Chen S, Liao G, Zhu H, Wei X, Cui Y, et al. Calpain-2 contributes to neuropathic pain following motor nerve injury via up-regulating interleukin-6 in DRG neurons. Brain Behav Immun. 2015;44:37-47 pubmed 出版商
  89. Srodulski S, Sharma S, Bachstetter A, Brelsfoard J, Pascual C, Xie X, et al. Neuroinflammation and neurologic deficits in diabetes linked to brain accumulation of amylin. Mol Neurodegener. 2014;9:30 pubmed 出版商
  90. Said A, Bock S, Müller G, Weindl G. Inflammatory conditions distinctively alter immunological functions of Langerhans-like cells and dendritic cells in vitro. Immunology. 2015;144:218-30 pubmed 出版商
  91. Sueur C, Lupo J, Mas P, Morand P, Boyer V. Difference in cytokine production and cell cycle progression induced by Epstein-Barr virus Lmp1 deletion variants in Kmh2, a Hodgkin lymphoma cell line. Virol J. 2014;11:94 pubmed 出版商
  92. Liu B, Cao Y, Huizinga T, Hafler D, Toes R. TLR-mediated STAT3 and ERK activation controls IL-10 secretion by human B cells. Eur J Immunol. 2014;44:2121-9 pubmed 出版商
  93. Keswani T, Bhattacharyya A. Differential role of T regulatory and Th17 in Swiss mice infected with Plasmodium berghei ANKA and Plasmodium yoelii. Exp Parasitol. 2014;141:82-92 pubmed 出版商
  94. Codeluppi S, Fernández Zafra T, Sandor K, Kjell J, Liu Q, Abrams M, et al. Interleukin-6 secretion by astrocytes is dynamically regulated by PI3K-mTOR-calcium signaling. PLoS ONE. 2014;9:e92649 pubmed 出版商
  95. Cuzzone D, Weitman E, Albano N, Ghanta S, Savetsky I, Gardenier J, et al. IL-6 regulates adipose deposition and homeostasis in lymphedema. Am J Physiol Heart Circ Physiol. 2014;306:H1426-34 pubmed 出版商
  96. Qian H, Shi J, Fan T, Lv J, Chen S, Song C, et al. Sophocarpine attenuates liver fibrosis by inhibiting the TLR4 signaling pathway in rats. World J Gastroenterol. 2014;20:1822-32 pubmed 出版商
  97. Gu L, Talati P, Vogiatzi P, Romero Weaver A, Abdulghani J, Liao Z, et al. Pharmacologic suppression of JAK1/2 by JAK1/2 inhibitor AZD1480 potently inhibits IL-6-induced experimental prostate cancer metastases formation. Mol Cancer Ther. 2014;13:1246-58 pubmed 出版商
  98. Buchegger P, Preininger C. Four assay designs and on-chip calibration: gadgets for a sepsis protein array. Anal Chem. 2014;86:3174-80 pubmed 出版商
  99. Xiang M, Birkbak N, Vafaizadeh V, Walker S, Yeh J, Liu S, et al. STAT3 induction of miR-146b forms a feedback loop to inhibit the NF-?B to IL-6 signaling axis and STAT3-driven cancer phenotypes. Sci Signal. 2014;7:ra11 pubmed 出版商
  100. Zhan Z, Xie X, Cao H, Zhou X, Zhang X, Fan H, et al. Autophagy facilitates TLR4- and TLR3-triggered migration and invasion of lung cancer cells through the promotion of TRAF6 ubiquitination. Autophagy. 2014;10:257-68 pubmed 出版商
  101. Gu H, Werner J, Bergmann F, Whitcomb D, Buchler M, Fortunato F. Necro-inflammatory response of pancreatic acinar cells in the pathogenesis of acute alcoholic pancreatitis. Cell Death Dis. 2013;4:e816 pubmed 出版商
  102. Nagy L, Grishina I, Macal M, Hirao L, Hu W, Sankaran Walters S, et al. Chronic HIV infection enhances the responsiveness of antigen presenting cells to commensal Lactobacillus. PLoS ONE. 2013;8:e72789 pubmed 出版商
  103. Svajger U, Obermajer N, Jeras M. IFN-?-rich environment programs dendritic cells toward silencing of cytotoxic immune responses. J Leukoc Biol. 2014;95:33-46 pubmed 出版商
  104. Parker B, Larsen M, Edvinsson L, Povlsen G. Signal transduction in cerebral arteries after subarachnoid hemorrhage-a phosphoproteomic approach. J Cereb Blood Flow Metab. 2013;33:1259-69 pubmed 出版商
  105. Aoshiba K, Tsuji T, Kameyama S, Itoh M, Semba S, Yamaguchi K, et al. Senescence-associated secretory phenotype in a mouse model of bleomycin-induced lung injury. Exp Toxicol Pathol. 2013;65:1053-62 pubmed 出版商
  106. Tripathi P, Wang Y, Coussens M, Manda K, Casey A, Lin C, et al. Activation of NFAT signaling establishes a tumorigenic microenvironment through cell autonomous and non-cell autonomous mechanisms. Oncogene. 2014;33:1840-9 pubmed 出版商
  107. Cao L, Li L, Lin D, Zuo Z. Isoflurane induces learning impairment that is mediated by interleukin 1? in rodents. PLoS ONE. 2012;7:e51431 pubmed 出版商
  108. Lemire B, Debigare R, Dubé A, Thériault M, Cote C, Maltais F. MAPK signaling in the quadriceps of patients with chronic obstructive pulmonary disease. J Appl Physiol (1985). 2012;113:159-66 pubmed 出版商
  109. Bartels E, Falbe Wätjen I, Littrup Andersen E, Danneskiold Samsøe B, Bliddal H, Ribel Madsen S. Rheumatoid factor and its interference with cytokine measurements: problems and solutions. Arthritis. 2011;2011:741071 pubmed 出版商
  110. Munster B, Aronica E, Zwinderman A, Eikelenboom P, Cunningham C, Rooij S. Neuroinflammation in delirium: a postmortem case-control study. Rejuvenation Res. 2011;14:615-22 pubmed 出版商
  111. BORCHERDING D, Hugo E, Idelman G, De Silva A, Richtand N, Loftus J, et al. Dopamine receptors in human adipocytes: expression and functions. PLoS ONE. 2011;6:e25537 pubmed 出版商
  112. Sharma S, Nemeth E, Chen Y, Goodnough J, Huston A, Roodman G, et al. Involvement of hepcidin in the anemia of multiple myeloma. Clin Cancer Res. 2008;14:3262-7 pubmed 出版商
  113. Graber J, Allie S, Mullen K, Jones M, Wang T, Krishnan C, et al. Interleukin-17 in transverse myelitis and multiple sclerosis. J Neuroimmunol. 2008;196:124-32 pubmed 出版商
  114. van Heteren J, Rozenberg F, Aronica E, Troost D, Lebon P, Kuijpers T. Astrocytes produce interferon-alpha and CXCL10, but not IL-6 or CXCL8, in Aicardi-Goutières syndrome. Glia. 2008;56:568-78 pubmed 出版商
  115. Denis M, Reenaers C, Fontaine F, Belaiche J, Louis E. Assessment of endoscopic activity index and biological inflammatory markers in clinically active Crohn's disease with normal C-reactive protein serum level. Inflamm Bowel Dis. 2007;13:1100-5 pubmed
  116. Takeda K, Suzuki T, Shimada S, Shida K, Nanno M, Okumura K. Interleukin-12 is involved in the enhancement of human natural killer cell activity by Lactobacillus casei Shirota. Clin Exp Immunol. 2006;146:109-15 pubmed
  117. Janke M, Witsch E, Mages H, Hutloff A, Kroczek R. Eminent role of ICOS costimulation for T cells interacting with plasmacytoid dendritic cells. Immunology. 2006;118:353-60 pubmed
  118. Kooijman R, Coppens A, Hooghe Peters E. Igf-I inhibits spontaneous apoptosis in human granulocytes. Endocrinology. 2002;143:1206-12 pubmed
  119. Suwa T, Hogg J, Vincent R, Mukae H, Fujii T, van Eeden S. Ambient air particulates stimulate alveolar macrophages of smokers to promote differentiation of myeloid precursor cells. Exp Lung Res. 2002;28:1-18 pubmed